[go: up one dir, main page]

RU2003115613A - ORAL DRUG CONTAINING SEA ALGAE TO REDUCE DENTAL DEPOSIT AND SPECIFICITY - Google Patents

ORAL DRUG CONTAINING SEA ALGAE TO REDUCE DENTAL DEPOSIT AND SPECIFICITY

Info

Publication number
RU2003115613A
RU2003115613A RU2003115613/15A RU2003115613A RU2003115613A RU 2003115613 A RU2003115613 A RU 2003115613A RU 2003115613/15 A RU2003115613/15 A RU 2003115613/15A RU 2003115613 A RU2003115613 A RU 2003115613A RU 2003115613 A RU2003115613 A RU 2003115613A
Authority
RU
Russia
Prior art keywords
calculus
plaque
seaweed
ascophyllum
mammal
Prior art date
Application number
RU2003115613/15A
Other languages
Russian (ru)
Other versions
RU2275218C2 (en
Inventor
Суне ВИКНЕР
Original Assignee
Сдк Свиденкэа Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003907A external-priority patent/SE0003907D0/en
Application filed by Сдк Свиденкэа Аб filed Critical Сдк Свиденкэа Аб
Publication of RU2003115613A publication Critical patent/RU2003115613A/en
Application granted granted Critical
Publication of RU2275218C2 publication Critical patent/RU2275218C2/en

Links

Claims (10)

1. Применение водоросли Ascophyllum sp. или ее экстракта для изготовления орального препарата для уменьшения зубного налета и/или конкремента у млекопитающего.1. The use of algae Ascophyllum sp. or an extract thereof for the manufacture of an oral preparation for reducing plaque and / or calculus in a mammal. 2. Применение по п.1, где млекопитающее выбирают из человека, кошки и собаки.2. The use according to claim 1, where the mammal is selected from a human, cat and dog. 3. Применение по п.1 или 2, где оральный препарат выбирают из порошка, суспензии, таблетки, таблетки с покрытием или капсулы.3. The use according to claim 1 or 2, wherein the oral preparation is selected from a powder, suspension, tablet, coated tablet or capsule. 4. Применение по любому из пп.1-3, где зубной налет выбирают из бактериального налета, артериосклеротических бляшек, атеросклеротических бляшек и плевральных бляшек, а конкремент выбирают из зубного камня, почечного конкремента, желчного конкремента и конкремента простаты.4. The use according to any one of claims 1 to 3, wherein the plaque is selected from bacterial plaque, arteriosclerotic plaques, atherosclerotic plaques and pleural plaques, and the calculus is selected from tartar, renal calculus, biliary calculus and prostate calculus. 5. Применение по любому из пп.1-4, где морская водоросль представляет собой Ascophyllum nodosum.5. The use according to any one of claims 1 to 4, where the seaweed is Ascophyllum nodosum. 6. Применение по п.5, где морская водоросль Ascophyllum nodosum имеет следующий установленный химический состав: 20-26% сульфатированных уроновых кислот в форме сложных эфиров, 5-8% маннита, 2-5% ламинарана, 5-15% фукоидина, 2,5-3,5% S, 2-3% К, 3-4% Cl, 3-4% Na, 0,5-1% Mg, 1-3% Са, 0,1-15% Р и 40-100 мг/кг Br, 1-10 мг Со, 1-10 мг Cu, 150-1000 мг Fe, 10-50 мг Mn, 700-1200 мг I, 20-200 мг Zn, 0,3-1 мг Мо, 2-5 мг Ni, 15-50 мг Ва, 1,5-3 мг V и 500-2000 мг/кг аскорбиновой кислоты, 150-300 мг/кг токоферолов, 30-60 мг/кг каротинов, 10-30 мг/кг ниацина, 0,1-0,4 мг/кг биотина, 0,2-1 мг/кг фолиевой кислоты, 5-10 мг/кг рибофлавина, 1-5 мг/кг тиамина, 0,004 мг/кг витамина В12 и 10 мг/кг витамина К.6. The use according to claim 5, where the seaweed Ascophyllum nodosum has the following established chemical composition: 20-26% sulfated uronic acids in the form of esters, 5-8% mannitol, 2-5% laminaran, 5-15% fucoidin, 2 , 5-3.5% S, 2-3% K, 3-4% Cl, 3-4% Na, 0.5-1% Mg, 1-3% Ca, 0.1-15% P and 40 -100 mg / kg Br, 1-10 mg Co, 1-10 mg Cu, 150-1000 mg Fe, 10-50 mg Mn, 700-1200 mg I, 20-200 mg Zn, 0.3-1 mg Mo , 2-5 mg Ni, 15-50 mg Ba, 1.5-3 mg V and 500-2000 mg / kg ascorbic acid, 150-300 mg / kg tocopherols, 30-60 mg / kg carotenes, 10-30 mg / kg of niacin, 0.1-0.4 mg / kg of biotin, 0.2-1 mg / kg of folic acid, 5-10 mg / kg of riboflavin, 1-5 mg / kg of thiamine, 0.004 mg / kg of vitamin B12 and 10 mg / kg vitamin K. 7. Единичная доза орального препарата, содержащая в качестве активного ингредиента уменьшающее зубной налет и/или конкремент у млекопитающего количество морской водоросли Ascophyllum sp. или ее экстракта.7. A single dose of an oral preparation containing, as an active ingredient, a plaque and / or calculus in a mammal that reduces the amount of seaweed Ascophyllum sp. or its extract. 8. Единичная доза орального лекарственного средства по п.7, где уменьшающее зубной налет и/или конкремент у млекопитающего количество морской водоросли Ascophyllum sp. составляет 250 мг - 1 г морской водоросли на единичную дозу.8. The unit dose of an oral medicament according to claim 7, wherein the mammal reduces plaque and / or calculus in an amount of seaweed Ascophyllum sp. is 250 mg - 1 g of seaweed per unit dose. 9. Единичная доза орального препарата по п.7 или 8, где морская водоросль Ascophyllum sp. представляет собой Ascophyllum nodosum.9. The unit dose of an oral preparation according to claim 7 or 8, wherein the seaweed Ascophyllum sp. represents Ascophyllum nodosum. 10. Способ профилактики и/или терапевтического лечения зубного налета и/или конкремента у млекопитающего, нуждающегося в этом, включающий введение указанному субъекту единичной дозы орального препарата по любому из пп.7-9.10. A method for the prevention and / or therapeutic treatment of plaque and / or calculus in a mammal in need thereof, comprising administering to a specified subject a unit dose of an oral preparation according to any one of claims 7 to 9.
RU2003115613/15A 2000-10-27 2001-09-27 Algae-containing oral remedy for dental plaque and concretion reducing and method for prophylaxis and/or therapy of dental plaque and concretion RU2275218C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0003907-3 2000-10-27
SE0003907A SE0003907D0 (en) 2000-10-27 2000-10-27 Composition for the elimination of tartar from the mouth

Publications (2)

Publication Number Publication Date
RU2003115613A true RU2003115613A (en) 2004-09-20
RU2275218C2 RU2275218C2 (en) 2006-04-27

Family

ID=20281587

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003115613/15A RU2275218C2 (en) 2000-10-27 2001-09-27 Algae-containing oral remedy for dental plaque and concretion reducing and method for prophylaxis and/or therapy of dental plaque and concretion

Country Status (22)

Country Link
US (1) US7125555B2 (en)
EP (1) EP1328285B1 (en)
JP (1) JP4648611B2 (en)
KR (1) KR100890723B1 (en)
CN (1) CN1230195C (en)
AT (1) ATE319463T1 (en)
AU (1) AU2001290473A1 (en)
BR (1) BRPI0114933B8 (en)
CA (1) CA2426936C (en)
CY (1) CY1105379T1 (en)
DE (1) DE60117824T2 (en)
DK (1) DK1328285T3 (en)
ES (1) ES2260286T3 (en)
IS (1) IS2288B (en)
MX (1) MXPA03003699A (en)
NO (1) NO329352B1 (en)
NZ (1) NZ525418A (en)
PT (1) PT1328285E (en)
RU (1) RU2275218C2 (en)
SE (1) SE0003907D0 (en)
SK (1) SK287572B6 (en)
WO (1) WO2002034279A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001269936A1 (en) * 2000-06-20 2002-01-02 Phycotransgenics, Llc Transgenic algae for delivering antigens to an animal
US6932980B1 (en) * 2001-01-18 2005-08-23 Richard Sayre Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
US20050267091A1 (en) * 2004-05-25 2005-12-01 Roger Berlin Compositions containing policosanol and niacin and/or niacin derivatives and their pharmaceutical uses
DE102004043945A1 (en) * 2004-09-11 2006-03-30 Henkel Kgaa Oral, dental and dental protease care products containing plaque-forming substances
EA200701932A1 (en) * 2007-08-29 2009-02-27 Общество С Ограниченной Ответственностью "Вдс" TABLET FOR PREVENTION AND TREATMENT OF TEETH DISEASES AND PERIODONTAL
FR2931071B1 (en) * 2008-05-14 2010-08-13 Roquette Freres ALGAE CONFECTIONERY FOR THE PREVENTION OF ORAL INFECTIONS
US20100183523A1 (en) * 2009-01-22 2010-07-22 Wagner Richard E Dental composition and method
EP2210582B1 (en) * 2009-01-22 2019-09-18 Solarvest Bioenergy Inc. Dental composition comprising algae and method for producing thereof
FR2968558B1 (en) * 2010-12-14 2013-03-22 Ys Lab COMPOSITION BASED ON ALKALA EXTRACT FOR ORAL USE
US8916179B2 (en) * 2011-10-25 2014-12-23 T.F.H. Publications, Inc. Ascophyllum nodosum animal chews
CN103877195A (en) * 2013-11-15 2014-06-25 东南大学 Formulation and administration method of traditional Chinese medicine for treating kidney stone
WO2020260955A2 (en) * 2019-03-27 2020-12-30 UPL Corporation Limited Plant treatment composition and method

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56117777A (en) * 1980-02-15 1981-09-16 Takanori Koshiro Diuretic health food
JPS56113269A (en) * 1980-02-15 1981-09-07 Takanori Koshiro Healthful food for promoting urination
FR2513122A1 (en) * 1981-09-23 1983-03-25 Goemar Sa NEW MEDICINES BASED ON ALGAE EXTRACTS AND CORRESPONDING FORMULATIONS
US4775525A (en) * 1985-12-16 1988-10-04 Ivo Pera Oral hygiene formulation containing sodium alginate
JP2691902B2 (en) * 1988-01-19 1997-12-17 日本製粉株式会社 Glucosyltransferase inhibitor and caries preventive oral composition
GB8803157D0 (en) 1988-02-11 1988-03-09 Nat Res Dev Denture protection
US4857331A (en) * 1988-03-31 1989-08-15 Warner-Lambert Company Sugarless pectin delivery system
JP3013060B2 (en) * 1991-11-16 2000-02-28 株式会社ロッテ Oral composition for inhibiting and detaching tooth decay from tooth decay
DE4219360C2 (en) * 1992-06-12 1994-07-28 Milupa Ag Process for the production of lipids with a high proportion of long-chain, highly unsaturated fatty acids
US6255296B1 (en) * 1994-01-11 2001-07-03 Endomatrix, Inc. Composition and method for treating a patient susceptible to or suffering from a cardiovascular disorder or disease
GB2292146A (en) * 1994-08-11 1996-02-14 Merck & Co Inc HIV protease inhibitors useful for the treatment of AIDS
RU2110986C1 (en) * 1995-04-04 1998-05-20 Товарищество с ограниченной ответственностью - Производственно-коммерческая фирма "Линда" Tooth elixir
ATE444760T1 (en) * 1997-01-13 2009-10-15 Univ Emory GLUTATHIONE FOR THE TREATMENT OF INFLUENCE INFECTIONS
US6338856B1 (en) * 1998-02-27 2002-01-15 Texas Tech University Seaweed supplement diet for enhancing immune response in mammals and poultry
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
GB9819530D0 (en) * 1998-09-09 1998-10-28 Smithkline Beecham Plc Novel compositions and use
RU2157174C1 (en) * 1999-03-29 2000-10-10 Архангельская государственная медицинская академия Means for preventing and treating initial forms of dental caries
RU2158125C1 (en) * 1999-11-17 2000-10-27 Санкт-Петербургская медицинская академия последипломного образования Composition for preventing and treating diseases of periodontium and oral cavity mucosa
JP4189620B2 (en) * 2000-03-01 2008-12-03 ライオン株式会社 Oral composition for periodontal disease prevention and treatment

Similar Documents

Publication Publication Date Title
US5875798A (en) Therapeutic toothpick for treating oral and systemic diseases
RU2003115613A (en) ORAL DRUG CONTAINING SEA ALGAE TO REDUCE DENTAL DEPOSIT AND SPECIFICITY
JP2764451B2 (en) Synergistic composition for treatment of periodontal disease and method of treatment
TWI566699B (en) Biofilm disruptive compositions and the use thereof
US5875799A (en) Therapeutic dental floss for treating systemic diseases
EP2263660A3 (en) Orally disintegrable tablets
JPH0597668A (en) Treatment of gum inflammation
Johansson et al. A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy
JP4648611B2 (en) Oral formulations containing seaweed for plaque and stone reduction
CA2240281A1 (en) Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
JP2004512309A5 (en)
JP2002515439A5 (en)
JP2760573B2 (en) Oral composition for inhibiting plaque adhesion
CN115361936A (en) Oral composition
JP2866393B2 (en) Oral composition for inhibiting plaque accumulation
RU99112967A (en) METHOD FOR TREATMENT AND PREVENTION OF PIG DYSENTERY
CA2518738A1 (en) Method and composition for preventing or reducing diarrhea
JPH07502044A (en) Oral composition for inhibiting plaque and tartar formation
US20050096383A1 (en) Method and composition for oral cavity hygiene
RU92011843A (en) COMPOSITION FOR PREVENTION OF PERIODONTAL DISEASES AND MUSCLE ORAL SHELL
JP2023154964A (en) Tooth surface deposit remover
RU17269U1 (en) RIFAMPICINE
US20090023692A1 (en) Compositions for inhibiting and preventing vascular occlusion containing nutritional supplements
TNSN95067A1 (en) 2,4-DISULFONYLE PHENYLBUTYLE NITRONE, ITS SALTS, AND THEIR USE AS PHARMACEUTICALS
RU98114839A (en) ANTI-BACTERIAL COMPOSITION CONTAINING NIZINE AND GLYCERINE MONOLAURATE - A DRUG FOR THE TREATMENT OF DISEASES CONDITIONED BY HELICOBACTER PYLORY BACTERIA